A neonatal death due to medium-chain acyl-CoA dehydrogenase deficiency: Utilization of the neonatal metabolic screen in a functional approach to sudden unexplained infant death

American Journal of Forensic Medicine and Pathology

Volumn 30, Issue 3, 2009, Pages 284-286

  Manoukian, Anthony A ^a   Ha, Chung Eun ^a   Seaver, Laurie H ^a   Bhagavan, Nadhipuram V ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

Fatty acid oxidation; Inborn errors of metabolism; Medium chain acyl CoA dehydrogenase (MCAD) deficiency; Newborn metabolic screen; Sudden unexplained infant death

Indexed keywords

FATTY ACID; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE;

APGAR SCORE; ARTICLE; AUTOPSY; BIOCHEMISTRY; CASE REPORT; CAUSE OF DEATH; CESAREAN SECTION; CHILD DEATH; DIET RESTRICTION; ENZYME DEFICIENCY; FATTY ACID OXIDATION; HISTORY; HUMAN; LABORATORY TEST; LIFE; MALE; NEWBORN; NEWBORN DEATH; NEWBORN SCREENING; PERINATAL DEATH; PHYSICIAN; RESUSCITATION; SUDDEN DEATH;

ACYL-COA DEHYDROGENASE; CARNITINE; GENE DELETION; HUMANS; INFANT, NEWBORN; LIPID METABOLISM, INBORN ERRORS; MALE; NEONATAL SCREENING; POINT MUTATION; SUDDEN INFANT DEATH;

EID: 69549120040     PISSN: 01957910     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAF.0b013e318187e09b     Document Type: Article

References (27)

1. WHO Library Cataloguing-in-Publication Data. Neonatal and Perinatal Mortality: Country, Regional and Global Estimates. Geneva, Switzerland: World Health Organization; 2006.
2. Corey TS, Hanzlick R, Howard J, et al. A functional approach to sudden unexplained infant deaths. Am J Forensic Med Pathol. 2007;28:271-277. (Pubitemid 47329751)
3. Garrod AE. The incidence of alkaptonuria: a study in chemical individuality. Lancet. 1902;2:1616-1620.
4. Penrose LS. Inheritance of phenylpyruvic amentia (phenylketonuria). Lancet. 1935;2:192-194.
5. Bickel H, Gerrard J, Hickmans EM. Influence of phenylalanine intake on phenylketonuria. Lancet. 1953;265:812-813.
6. Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics. 1963;32:338-343.
7. Tarini BA, Freed GL. Keeping up with the newborn screening revolution [serial online]. Contemp Pediatr. 2007;24:36-50.
8. Wilcken B, Wiley V, Hammond J, et al. Screening newborns for inborn errors of metabolism by mass tandem spectrometry. N Engl J Med. 2003;348:2304-2312. (Pubitemid 36638104)
9. WHO. International Classification of Diseases, 10th Revision. Geneva, Switzerland: World Health Organization; 1994.
10. Lansky S, Franca E, Kawachi I. Social inequalities in perinatal mortality in Belo Horizonte, Brazil: the role of Hospital care. Am J Public Health. 2007;97:867-873. (Pubitemid 47280133)
11. Wigglesworth JS. Causes and classification of fetal and perinatal death. In: Wigglesworth JS, Singer DB, eds. Textbook of Fetal and Perinatal Pathology. Cambridge, MA: Blackwell Scientific; 1991:77-91.
12. Bound JP, Butler NR, Spector WG. Classification and causes of perinatal mortality. Br Med J. 1956;2:1191-1196.
13. Hey EN, Lloyd DJ, Wigglesworth JS. Classifying perinatal death: fetal and neonatal factors. Br J Obstet Gynaecol. 1986;93:1213-1223. (Pubitemid 17196560)
14. Wigglesworth JS. Monitoring perinatal mortality: a pathophysiological approach. Lancet. 1980;2:684-686. (Pubitemid 10048662)
15. Chace DH, Hillman SL, Van Hove, et al. Rapid diagnosis of MCAD deficiency: quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrophotometry. Clin Chem. 1997;43:2106-2113.
16. Andresen BS, Bross P, Jensen TG, et al. A rare disease-associated mutation in the medium-chain acyl-CoA dehydrogenase (MCAD) gene changes a conserved arginine, previously shown to be functionally essential in shortchain acyl-CoA dehydrogenase (SCAD). Am J Hum Genet. 1993;53:730-739. (Pubitemid 23304146)
17. Blois B, Riddell C, Dooley K, et al. Newborns with C8-acylcarnitine level over the 90th centile have an increased frequency of the common MCAD 985A>G mutation. J Inherit Metab Dis. 2005;28:551-556. (Pubitemid 40753683)
18. Chalmers RA, Stanley CA, English N, et al. Mitochondrial carnitine-acylcarnitine translocase deficiency presenting as sudden neonatal death. J Pediatr. 1997;131:220-225.
19. Wang SS, Fernhoff PM, Hannon WH, et al. Medium chain acyl-CoA dehydrogenase deficiency human genome epidemiology review. Genet Med. 1999;1:332-339. (Pubitemid 129736037)
20. Brackett JC, Sims HF, Steiner RD, et al. A novel mutation in medium chain acyl-CoA dehydrogenase causes sudden neonatal death. J Clin Invest. 1994;94:1477-1483.
21. Ensenauer R, Winters JL, Parton PA, et al. Genotypic differences of MCAD deficiency in the Asian population: novel genotype and clinical symptoms preceding newborn screening notification. Genet Med. 2005;7:339-343. (Pubitemid 40827583)
22. Korman SH, Gutman A, Brooks R, et al. Homozygosity for a severe novel medium-chain acyl-CoA dehydrogenase (MCAD) mutation IVS3-1G>C that leads to introduction of a premature termination codon by complete missplicing of the MCAD mRNA and is associated with phenotypic diversity ranging from sudden neonatal death to asymptomatic status. Mol Genet Metab. 2004;82:121-129. (Pubitemid 38692549)
23. Raymond K, Bale AE, Barnes CA, et al. Medium-chain acyl-CoA dehydrogenase deficiency: sudden and unexpected death of a 45-year-old woman, Genet Med. 1999;1:293-294. (Pubitemid 129736032)
24. Tajima G, Sakura N, Ono H, et al. Differential diagnosis of neonatal hypergalactosaemia detected by mass screening: clinical significance of portal vein imaging. J Inherit Metab Dis. 2004;27:11-18. (Pubitemid 38418191)
25. Bhagavan NV. Fatty acids and eicosanoids. In: Medical Biochemistry. San Diego, CA: Harcourt/Academic Press; 2002:365-399.
26. Bhagavan NV. Metabolic homeostasis. In: Medical Biochemistry. San Diego, CA: Harcourt/Academic Press; 2002:485-519.
27. Roe CR, Ding JH. Mitochondrial Fatty Acid Oxidation Disorders. New York, NY: McGraw-Hill; 2001.